Advertisement
Decriminalizing Marijuana: Assessing Unintentional Pediatric Exposure

Decriminalizing Marijuana: Assessing Unintentional Pediatric Exposure

Throughout the United States, the legalization of marijuana is being debated by the public and in government forums. Although still criminalized at the federal level, decriminalization at the state level has received national attention because several states have enacted marijuana legislation for medical and recreational purposes. As of 2013, 18 states and the District of Columbia have passed legislation allowing for the use of medical marijuana, which includes many edible products, and sales are projected to more than double by 2015. More recently, Washington and Colorado have decriminalized small amounts of recreational marijuana. In 2004, the American Academy of Pediatrics released a policy statement that expressed concern about potential abuse of marijuana among adolescents in the context of decriminalization. There has been some evidence of medical marijuana being diverted to adolescents and recent reports of marijuana exposure to younger children. Studies suggest that there has been a slight increase in symptomatic, unintentional marijuana exposures since 2009. “Most of these exposures were from medical marijuana, which was often packaged as food products,” explains George S. Wang, MD, FAAP. “As such, it’s important to examine the effect that decriminalizing marijuana has had on children.” Assessing Trends in Marijuana Exposure In a study from Annals of Emergency Medicine, Dr. Wang and colleagues compared trends in unintentional marijuana exposures to children up to the age of 9 as measured by call volumes that were reported to U.S. poison centers. The authors hypothesized that decriminalized and transitional states would experience greater increases in call volume and have more symptomatic exposures and healthcare admissions than non-legal states. “States that decriminalized marijuana had significant increases in...
ATS 2014

ATS 2014

New research is being presented at ATS 2014, the American Thoracic Society’s annual meeting, from May 16 to 21 in San Diego. Meeting Highlights Risk Factors for Near-Fatal Asthma Maternal Smoking, Pediatric Asthma, & ED Visits Predicting Pediatric Sepsis in the ED Examining Mortality After LVRS Positive Airway Pressure Helpful in Bariatric Surgery Subclinical COPD & Comorbidities in Surgical Patients Patients Miss Signs of Severe Asthma Counseling Patients About Tobacco Use Gender Differences in COPD   News From the Meeting Sleep Apnea: Skipping Sleep Lab Found Cost-Effective PTSD Common Following ICU Stay Cystic Fibrosis: Once-A-Day Antibiotic Durable Sepsis a Factor in Many Hospital Deaths, Investigators Say Pirfenidone Slows Decline in Idiopathic Pulmonary Fibrosis Novel Biologic Promising for Allergic Asthma Vitamin C May Save Newborn’s Lungs When Mom Smokes Bronchial Gene Test Rules Out Lung Cancer Lung Foam Disappoints in COPD Does Tylenol Protect Kidneys in Sepsis? Vitamin D Flops as Asthma Therapy Booster Sepsis Contributes to Half of all Hospital Deaths Antioxidant No Help in IPF Nintedanib Slows IPF Progression IPF Survival Better With Novel Drug? Statins Flop in Sepsis and COPD ATS: New Leader to Push for Clinicians in Research Pulmonary Fibrosis, COPD, and Asthma Highlight ATS Meeting IPF Takes Stage at ATS   More From the Meeting Welcome Letter Registration General Information Program Overview Program At-a-Glance Abstracts Search & Itinerary CME & Nursing CE Enduring Materials Maintenance of Certification Meetings & Events Programs for Trainees Specialty Tracks Housing Information Travel Information Resource Centers Tours During ATS 2014 Twitter Scavenger Hunt ATS Convention Camp Exhibit Hall Foundation Research Program Benefit Navy Bay Bridge Run/Walk Physician Payments Sunshine...
[ HIDE/SHOW ]